<div id="readability-page-1"><p>Neuberger Berman Group LLC reduced its position in  Icon Plc (NASDAQ:ICLR - Free Report) by 72.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 208,286 shares of the medical research company's stock after selling 553,413 shares during the quarter. Neuberger Berman Group LLC owned 0.26% of Icon worth $30,289,000 as of its most recent SEC filing.</p><ul><li>3 Healthcare Pathbreakers With Long-Term Tailwinds</li></ul><p>Several other large investors have also modified their holdings of ICLR. Geneos Wealth Management Inc. raised its holdings in shares of  Icon by 11.5% in the second quarter. Geneos Wealth Management Inc. now owns 541 shares of the medical research company's stock worth $79,000 after buying an additional 56 shares during the period.  First National Bank Sioux Falls grew its position in  Icon by 5.7% in the 2nd quarter. First National Bank Sioux Falls now owns 1,580 shares of the medical research company's stock valued at $230,000 after acquiring an additional 85 shares during the last quarter.  Mutual Advisors LLC grew its position in  Icon by 3.6% in the 2nd quarter. Mutual Advisors LLC now owns 2,698 shares of the medical research company's stock valued at $392,000 after acquiring an additional 93 shares during the last quarter.  Hunter Perkins Capital Management LLC increased its stake in  Icon by 0.4% in the second quarter. Hunter Perkins Capital Management LLC now owns 22,399 shares of the medical research company's stock worth $3,258,000 after purchasing an additional 97 shares during the period.  Finally, SkyView Investment Advisors LLC lifted its position in shares of  Icon by 1.8% during the second quarter. SkyView Investment Advisors LLC now owns 6,321 shares of the medical research company's stock worth $914,000 after purchasing an additional 113 shares during the last quarter. Hedge funds and other institutional investors own  95.61% of the company's stock. </p><h2>Icon Stock Performance</h2><p>ICLR stock opened at $186.58 on Friday. Icon Plc has a one year low of $125.10 and a one year high of $228.29. The firm has a 50-day simple moving average of $176.51 and a two-hundred day simple moving average of $166.68. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.06 and a current ratio of 1.06. The firm has a market cap of $15.07 billion, a price-to-earnings ratio of 25.25, a PEG ratio of 3.41 and a beta of 1.25. </p><h2>Analyst Ratings Changes</h2><ul><li>Should You Bring The Luck Of The Irish To Your Investmets?</li></ul><p>Several research firms recently commented on ICLR. Weiss Ratings  reaffirmed a &#34;hold (c-)&#34; rating on shares of Icon in a research note on Monday, December 1st. Robert W. Baird  set a $220.00 price target on shares of Icon in a research note on Friday, October 24th. Citigroup  reiterated a &#34;neutral&#34; rating and issued a $200.00 price target (down previously from $225.00) on shares of Icon in a report on Thursday, August 21st. UBS Group  set a $220.00 price objective on Icon in a report on Friday, October 24th. Finally, Zacks Research upgraded Icon from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a report on Tuesday, November 25th. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and ten have given a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $205.00.</p><p><b>Read Our Latest Stock Analysis on ICLR</b></p><h2>About Icon</h2> (Free Report)<p>ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.</p><h2>Read More</h2><ul><li>Five stocks we like better than Icon</li><li>A Deeper Look at Bid-Ask Spreads</li><li>Disney's $1 Billion Deal Brings Its Magic to OpenAI</li><li>Growth Investing: Should You Adopt This Investing Strategy in 2022?</li><li>Why Amazon Could Be a $300 Stock Within Weeks</li><li>Where Do I Find 52-Week Highs and Lows?</li><li>Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside</li></ul><p><strong>Want to see what other hedge funds are holding ICLR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon Plc (NASDAQ:ICLR - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNMUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNMUg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Icon Right Now?</h2><p>Before you consider Icon, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Icon wasn't on the list.</p><p>While Icon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ICLR

<p>Neuberger Berman Group LLC sold 553,413 shares of Icon Plc, reducing its stake by 72.7% in Q2. Icon's stock opened at $186.58, with a market cap of $15.07 billion. Analysts have mixed ratings, with a consensus of "Moderate Buy" and an average price target of $205.00. Institutional investors own 95.61% of Icon's stock.</p>

Neuberger Berman Group LLC Sells 553,413 Shares of Icon Plc $ICLR